Business Context and Reporting Period
This Form 6-K filing by NeuroSense Therapeutics Ltd. covers the month of May 2022. The document serves as a notice to shareholders regarding the scheduling of the Company's Annual General Meeting.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a corporate governance notice and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing.
Guidance, Outlook, and Corporate Actions
- Annual General Meeting: The Company has scheduled its Annual General Meeting of Shareholders for June 21, 2022, at 11:00 a.m. Israel time.
- Location: The meeting will be held at the Company's offices at 11 Hamenofim St., Building B, Herzliya 4672562, Israel.
- Exhibit: A Notice of the Annual General Meeting is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the date and time of the Annual General Meeting (June 21, 2022, 11:00 a.m. Israel time).
- Confirm the physical location of the meeting in Herzliya, Israel.
- Review the attached Notice of Annual General Meeting (Exhibit 99.1) for specific agenda items and voting procedures.